Bionano Genomics Inc (BNGO) SEC News Jan. 12, 2026, 13:15 UTC (99% Positive) Bionano Genomics Inc (BNGO) Reports Q1 2026 Financial Results Full text
Register to leave comments News bot Jan. 29, 2026, 8:34 p.m. 📋 Bionano Genomics Inc (BNGO) - Financial Results Filing Date: 2026-01-12 Accepted: 2026-01-12 08:15:51 Event Type: Financial Results Event Details: Bionano Genomics Inc (BNGO) Reports the reporting period Financial Results Bionano Genomics Inc (BNGO) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: $7 Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: $7 📊 Key Financial Metrics: Metric Value Revenue $7 Cash $7 💼 Business Developments: PartnershipAcquisitionLicensing: Not availableRegulatory Approval: Not availableExecutive Changes: Not available Structured Data: Company Name: Bionano Genomics IncTicker Symbol: BNGO
📋 Bionano Genomics Inc (BNGO) - Financial Results
Filing Date: 2026-01-12
Accepted: 2026-01-12 08:15:51
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
Structured Data: